Related references
Note: Only part of the references are listed.Recent Developments in Non-HPV-related Adenocarcinomas of the Lower Female Genital Tract and Their Precursors
W. Glenn McCluggage
ADVANCES IN ANATOMIC PATHOLOGY (2016)
Gardasil-9: A global survey of projected efficacy
Lukai Zhai et al.
ANTIVIRAL RESEARCH (2016)
Age-specific prevalence of HPV16/18 genotypes in cervical cancer: A systematic review and meta-analysis
Anne Hammer et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study
Katsiaryna Holl et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
Mona Saraiya et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
E. A. Joura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Laser capture microdissection as a tool to evaluate human papillomavirus genotyping and methylation as biomarkers of persistence and progression of anal lesions
Alyssa M. Cornall et al.
BMJ OPEN (2015)
US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
Mona Saraiya et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease
Elmar A. Joura et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Prevalence of Human Papillomavirus Types in Invasive Cervical Cancers From 7 US Cancer Registries Before Vaccine
Claudia Hopenhayn et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2014)
Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer
Gordana Halec et al.
JOURNAL OF PATHOLOGY (2014)
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
Sepehr N. Tabrizi et al.
LANCET INFECTIOUS DISEASES (2014)
Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey
Julia M. L. Brotherton et al.
VACCINE (2014)
How best to interpret mixed human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia lesions
Emma T. Callegari et al.
VACCINE (2014)
Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination
Jeanne M. Pimenta et al.
BMC CANCER (2013)
Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
Dorota M. Gertig et al.
BMC MEDICINE (2013)
Age-Specific Occurrence of HPV16-and HPV18-Related Cervical Cancer
Silvia de Sanjose et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Laser capture microdissection shows HPV11 as both a causal and a coincidental infection in cervical cancer specimens with multiple HPV types
Nuria Guimera et al.
HISTOPATHOLOGY (2013)
Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with low-risk HPV genotypes 6 and 11
Alyssa M. Cornall et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data
Hammad Ali et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Fall in Human Papillomavirus Prevalence Following a National Vaccination Program
Sepehr N. Tabrizi et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer
Daan Geraets et al.
JOURNAL OF PATHOLOGY (2012)
One virus, one lesionuindividual components of CIN lesions contain a specific HPV type
Wim Quint et al.
JOURNAL OF PATHOLOGY (2012)
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Beatriz Serrano et al.
INFECTIOUS AGENTS AND CANCER (2012)
Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program
Suzanne M. Garland et al.
BMC MEDICINE (2011)
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication
Ni Li et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
Julia M. L. Brotherton et al.
LANCET (2011)
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
Basil Donovan et al.
LANCET INFECTIOUS DISEASES (2011)
Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia
Dorota M. Gertig et al.
SEXUAL HEALTH (2011)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants
Nicolas Wentzensen et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States
Ralph P. Insinga et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
How much cervical cancer in Australia is vaccine preventable? A meta-analysis
Julia M. L. Brotherton
VACCINE (2008)
Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne
M. P. Stevens et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Share Paper
